Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on November 29, 2017. The report addresses a specific corporate finance event rather than providing periodic financial results.
Key Financial Metrics
The filing does not report revenue, profit, cash flow, margins, or liquidity metrics. The primary financial data point disclosed is the scope of a debt repurchase program:
- Tender Offer Size: Up to $836.347 million aggregate principal amount.
- Target Securities: 6.375% Notes due 2037, 5.950% Notes due 2034, 5.850% Notes due 2036, 5.800% Notes due 2040, and 5.100% Notes due 2044.
Material Changes
The material change reported is the announcement of the results and pricing of the "Maximum Tender Offer" for the company's outstanding notes. The filing incorporates by reference press releases detailing the specific acceptance rates and pricing terms, but the text of the 8-K itself does not quantify the final amount of debt retired or the specific premium paid.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of new risks. The event is a routine debt management transaction. No unusual items or contingencies are described in the body of this report.
Investor Verification Checklist
- Verify the final amount of debt successfully retired in the tender offer by reviewing the attached press releases (Exhibits 99.1 and 99.2).
- Confirm the specific pricing premium paid to bondholders to calculate the total cash outflow.
- Check subsequent filings to determine the impact of this debt reduction on the company's overall leverage ratios.